Sign In
Buy WAT
$357.20
-1.05 (-0.293%)
At Close: Jun 23, 2026
Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sam
Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. Delivers up to 2x increase in resolving powe
Why Is Waters (WAT) Up 8.7% Since Last Earnings Report?
12:35pm, Thursday, 04'th Jun 2026
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
04:02pm, Wednesday, 03'rd Jun 2026
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
08:00am, Wednesday, 03'rd Jun 2026
FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics. Achieves a 3-hour faster time to detection (~15
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
08:00am, Monday, 01'st Jun 2026
>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease si
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research
08:00am, Monday, 01'st Jun 2026
Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. Ide
Carnival: Calm Waters Despite Fuel Price Headwinds
01:46am, Sunday, 31'st May 2026
Carnival has stabilized after a strong rally, with shares flat since August amid solid fundamentals and macro headwinds. Carnival reported strong Q1 2026 results: 6% revenue growth, 11% operating earn
Waters Corporation to Present at the Jefferies Global Healthcare Conference
04:00pm, Monday, 18'th May 2026
MILFORD, Mass., May 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Understanding Waters (WAT) Reliance on International Revenue
10:16am, Thursday, 14'th May 2026
Examine the evolution of Waters' (WAT) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues
02:35pm, Thursday, 07'th May 2026
Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.
Conrad Industries Is Worth The Volatile Waters The Industry Faces
02:08am, Wednesday, 06'th May 2026
Conrad Industries is a small-cap shipbuilder trading at a discount to heavy equipment peers, supported by recent revenue and profitability improvements. CNRD shifted from a $27 million net loss in 202
Waters Corporation (WAT) Q1 2026 Earnings Call Transcript
01:41pm, Tuesday, 05'th May 2026
Waters Corporation (WAT) Q1 2026 Earnings Call Transcript
Waters raises annual profit forecast as biosciences unit drives growth
10:38am, Tuesday, 05'th May 2026
Lab equipment maker Waters raised its annual profit forecast on Tuesday after beating quarterly estimates, driven by robust demand for drug development tools and the strong performance of its bi
Waters (WAT) Beats Q1 Earnings and Revenue Estimates
08:27am, Tuesday, 05'th May 2026
Waters (WAT) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.25 per share a year ago.
